Cargando…
Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea”
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131125/ https://www.ncbi.nlm.nih.gov/pubmed/30078127 http://dx.doi.org/10.1007/s40268-018-0242-z |
| _version_ | 1783354042477445120 |
|---|---|
| author | Gil, Daniel |
| author_facet | Gil, Daniel |
| author_sort | Gil, Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6131125 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61311252018-09-12 Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea” Gil, Daniel Drugs R D Letter to the Editor Springer International Publishing 2018-08-04 2018-09 /pmc/articles/PMC6131125/ /pubmed/30078127 http://dx.doi.org/10.1007/s40268-018-0242-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Gil, Daniel Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea” |
| title | Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea” |
| title_full | Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea” |
| title_fullStr | Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea” |
| title_full_unstemmed | Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea” |
| title_short | Comments on: “In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea” |
| title_sort | comments on: “in vitro safety pharmacology profiling of topical α-adrenergic agonist treatments for erythema of rosacea” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131125/ https://www.ncbi.nlm.nih.gov/pubmed/30078127 http://dx.doi.org/10.1007/s40268-018-0242-z |
| work_keys_str_mv | AT gildaniel commentsoninvitrosafetypharmacologyprofilingoftopicalaadrenergicagonisttreatmentsforerythemaofrosacea |